Signaturefd, LLC Verve Therapeutics, Inc. Transaction History

Signaturefd, LLC

$5.21 Billion
Q4 2024

A detailed history of Signaturefd, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,889 shares of VERV stock, worth $10,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,889

Previous 2,054 8.03%

Holding current value

$10,465

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$4.5 - $7.19 $742 - $1,186	-165 Reduced 8.03%	1,889 $10,000
Q3 2024 Oct 21, 2024	BUY	$4.4 - $7.86 $6,089 - $10,878	1,384 Added 206.57%	2,054 $9,000
Q2 2024 Jul 29, 2024	BUY	$4.76 - $12.79 $2,403 - $6,458	505 Added 306.06%	670 $3,000
Q1 2024 May 03, 2024	SELL	$10.81 - $17.96 $378 - $628	-35 Reduced 17.5%	165 $2,000
Q4 2023 Jan 31, 2024	BUY	$8.84 - $18.7 $1,352 - $2,861	153 Added 325.53%	200 $2,000
Q3 2023 Nov 03, 2023	BUY	$11.42 - $20.82 $536 - $978	47 New	47 $0

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $332M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account